288 related articles for article (PubMed ID: 24589721)
1. Focal segmental glomerulosclerosis: towards a better understanding for the practicing nephrologist.
Sethi S; Glassock RJ; Fervenza FC
Nephrol Dial Transplant; 2015 Mar; 30(3):375-84. PubMed ID: 24589721
[TBL] [Abstract][Full Text] [Related]
2. Podocyte foot process effacement as a diagnostic tool in focal segmental glomerulosclerosis.
Deegens JK; Dijkman HB; Borm GF; Steenbergen EJ; van den Berg JG; Weening JJ; Wetzels JF
Kidney Int; 2008 Dec; 74(12):1568-76. PubMed ID: 18813290
[TBL] [Abstract][Full Text] [Related]
3. Differentiating Primary, Genetic, and Secondary FSGS in Adults: A Clinicopathologic Approach.
De Vriese AS; Sethi S; Nath KA; Glassock RJ; Fervenza FC
J Am Soc Nephrol; 2018 Mar; 29(3):759-774. PubMed ID: 29321142
[TBL] [Abstract][Full Text] [Related]
4. Focal and Segmental Glomerulosclerosis and Membranous Nephropathy overlapping in a patient with Nephrotic Syndrome: a case report.
Silva CAD; Custódio FB; Monteiro MLGDR; Araújo SA; Araújo LS; Côrrea RRM; Reis MAD; Machado JR
J Bras Nefrol; 2020 Mar; 42(1):113-117. PubMed ID: 30806447
[TBL] [Abstract][Full Text] [Related]
5. Focal Segmental Glomerulosclerosis: State-of-the-Art and Clinical Perspective.
Shabaka A; Tato Ribera A; Fernández-Juárez G
Nephron; 2020; 144(9):413-427. PubMed ID: 32721952
[TBL] [Abstract][Full Text] [Related]
6. Epithelial cell foot process effacement in podocytes in focal and segmental glomerulosclerosis: a quantitative analysis.
Kfoury H
Ultrastruct Pathol; 2014 Oct; 38(5):303-8. PubMed ID: 24956069
[TBL] [Abstract][Full Text] [Related]
7. [Minimal change disease and focal segmental glomerulosclerosis].
Müller-Deile J; Schenk H; Schiffer M
Internist (Berl); 2019 May; 60(5):450-457. PubMed ID: 30887070
[TBL] [Abstract][Full Text] [Related]
8. What are we missing in the clinical trials of focal segmental glomerulosclerosis?
Zand L; Glassock RJ; De Vriese AS; Sethi S; Fervenza FC
Nephrol Dial Transplant; 2017 Jan; 32(suppl_1):i14-i21. PubMed ID: 28391338
[TBL] [Abstract][Full Text] [Related]
9. Spontaneous remission of genetic, apparent primary, FSGS presenting with nephrotic syndrome challenges traditional notions of primary FSGS.
Oo SZMWH; Freese ME; Holanda DG; Thomas CP
J Nephrol; 2021 Feb; 34(1):255-258. PubMed ID: 32852700
[No Abstract] [Full Text] [Related]
10. Pathologic classification of focal segmental glomerulosclerosis.
D'Agati V
Semin Nephrol; 2003 Mar; 23(2):117-34. PubMed ID: 12704572
[TBL] [Abstract][Full Text] [Related]
11. Secondary Focal Segmental Glomerulosclerosis: From Podocyte Injury to Glomerulosclerosis.
Kim JS; Han BG; Choi SO; Cha SK
Biomed Res Int; 2016; 2016():1630365. PubMed ID: 27088082
[TBL] [Abstract][Full Text] [Related]
12. Focal and segmental glomerulosclerosis: clinical and kidney biopsy correlations.
Sethi S; Zand L; Nasr SH; Glassock RJ; Fervenza FC
Clin Kidney J; 2014 Dec; 7(6):531-7. PubMed ID: 25503953
[TBL] [Abstract][Full Text] [Related]
13. [Nephrotic syndrom with focal and segmental glomerulosclerosis in Dakar: epidemiological and clinicopathological characteristics (about 134 cases)].
Niang A; Dial C; Ka EF; Lèye A; Pouye A; Ka MM; Mbengue M; Droz D; Diouf B
Dakar Med; 2008; 53(1):45-51. PubMed ID: 19102117
[TBL] [Abstract][Full Text] [Related]
14. Precise clinicopathologic findings for application of genetic testing in pediatric kidney transplant recipients with focal segmental glomerulosclerosis/steroid-resistant nephrotic syndrome.
Miura K; Kaneko N; Hashimoto T; Ishizuka K; Shirai Y; Hisano M; Chikamoto H; Akioka Y; Kanda S; Harita Y; Yamamoto T; Hattori M
Pediatr Nephrol; 2023 Feb; 38(2):417-429. PubMed ID: 35655039
[TBL] [Abstract][Full Text] [Related]
15. Focal Segmental Glomerulosclerosis.
Rosenberg AZ; Kopp JB
Clin J Am Soc Nephrol; 2017 Mar; 12(3):502-517. PubMed ID: 28242845
[TBL] [Abstract][Full Text] [Related]
16. Monogenic focal segmental glomerulosclerosis: A conceptual framework for identification and management of a heterogeneous disease.
Sambharia M; Rastogi P; Thomas CP
Am J Med Genet C Semin Med Genet; 2022 Sep; 190(3):377-398. PubMed ID: 35894442
[TBL] [Abstract][Full Text] [Related]
17. [Nephrotic syndrome in minimal change disease (kidney), focal segmental glomerulosclerosis, and focal mesangioproliferative glomerulonephritis].
Voznesenskaia TS; Sergeeva TV
Ter Arkh; 2002; 74(6):31-3. PubMed ID: 12136479
[TBL] [Abstract][Full Text] [Related]
18. [Value of soluble urokinase receptor serum levels in the differential diagnosis between idiopathic and secondary focal segmental glomerulosclerosis].
Segarra A; Jatem E; Quiles MT; Arbós MA; Ostos H; Valtierra N; Carnicer C; Salcedo MT
Nefrologia; 2014; 34(1):53-61. PubMed ID: 24463863
[TBL] [Abstract][Full Text] [Related]
19. Review on diagnosis and treatment of focal segmental glomerulosclerosis.
Deegens JK; Steenbergen EJ; Wetzels JF
Neth J Med; 2008 Jan; 66(1):3-12. PubMed ID: 18219061
[TBL] [Abstract][Full Text] [Related]
20. Advances in molecular diagnosis and therapeutics in nephrotic syndrome and focal and segmental glomerulosclerosis.
Sharif B; Barua M
Curr Opin Nephrol Hypertens; 2018 May; 27(3):194-200. PubMed ID: 29465426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
